|
publications
|
Title |
Submitted |
File |
 |
EFSPI Position Paper on Access to Clinical Trial Data
Description:
Postion Paper on Access to Clinical Trial Data |
May 2013 |
VIEW DOCUMENT |
|
The draft FDA guideline on non-inferiority clinical trials: a critical review from European
pharmaceutical industry statisticians
Description:
Pharmaceutical Statistics, 2011 |
September 2011 |
VIEW DOCUMENT |
|
Position Paper on JAMA editorial policy
Description:
Position paper |
January 2006 |
VIEW DOCUMENT |
|
Position Paper on JAMA editorial policy (cover letter)
Description:
Letter to JAMA editor |
January 2006 |
VIEW DOCUMENT |
|
Visions on the role of Statisticians in the Pharmaceutical Industry
Description:
Oral presentation by Merete Jørgensen, President EFSPI, VP Biostatistics, Novo Nordisk A/S
10 years anniversary of PSDM and BSS, Beerse, Belgium, December 2, 2003 |
December 2003 |
VIEW DOCUMENT |
|
Choice of Control in Clinical Trials - Issues and Implications of ICH-E10
Description:
Paper submitted on behalf of EFSPI; Drug Information Journal, Vol 35, pp 1147-1156, 2001 |
June 2001 |
VIEW DOCUMENT |
|
Qualified Statisticians in the European Pharmaceutical Industry: Report of a EFSPI Working Group
Description:
Drug Information Journal, Vol.33, pp 407-415, 1999 |
July 1999 |
VIEW DOCUMENT |
|
A European Concept for Good Statistical Practices in Global Drug Development: Report of a DIA/EFSPI workshop
Description:
Drug Information Journal, Vol 29, pp 471-510, 1995 |
July 1995 |
VIEW DOCUMENT |
|
|
